Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Syndax Pharmaceuticals (SNDX) Revenue (2016 - 2020)

Syndax Pharmaceuticals (SNDX) has 6 years of Revenue data on record, last reported at $380000.0 in Q4 2020.

  • For Q4 2020, Revenue changed 0.0% year-over-year to $380000.0; the TTM value through Sep 2021 reached $380000.0, down 74.95%, while the annual FY2025 figure was $172.4 million, 627.84% up from the prior year.
  • Revenue reached $380000.0 in Q4 2020 per SNDX's latest filing, roughly flat from $379000.0 in the prior quarter.
  • Across five years, Revenue topped out at $1.2 million in Q4 2017 and bottomed at $305000.0 in Q1 2016.
  • Average Revenue over 5 years is $393950.0, with a median of $379000.0 recorded in 2018.
  • Peak YoY movement for Revenue: surged 1694.12% in 2016, then plummeted 68.15% in 2018.
  • A 5-year view of Revenue shows it stood at $305000.0 in 2016, then surged by 291.15% to $1.2 million in 2017, then tumbled by 68.15% to $380000.0 in 2018, then changed by 0.0% to $380000.0 in 2019, then changed by 0.0% to $380000.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Revenue were $380000.0 in Q4 2020, $379000.0 in Q3 2020, and $379000.0 in Q2 2020.